Market Cap
₹2,441 Cr.
P/E
18.16
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
9.23%
3yr Average
18.85%
5yr Average
30.17%
Net Profit Margin
Latest
6.28%
3yr Average
12.18%
5yr Average
13.93%
ROCE
Latest
13.1%
3yr Average
24.63%
5yr Average
38.5%
Debt to Equity
Latest
0.05
3yr Average
0.03
5yr Average
0.15
Market Share
35% (as of Mar 24)
Ibuprofen - Global Market Share
30% (as of Mar 24)
Isobutyl Benzene (IBB) Global Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Capex

locked
Source
|
Latest
|
locked
Historic

Raw Material Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Manufacturing Capacity - Ibuprofen (MTPA)
    • Manufacturing Capacity - Metformin (MTPA)
    • Manufacturing Capacity - Ethyl Acetate (MTPA)
    • Manufacturing Capacity - Acetyl Chloride (MTPA)
    • Manufacturing Capacity - Paracetamol (MTPA)
    • Manufacturing Capacity - Isobutyl Benzene (IBB) (MTPA)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Suppliers
    Customers
    Company Filing
    Show Previous Years
    Discussions & Analysis